Intermediate-Size Patient Population Expanded Access Program for Intravenous Difelikefalin

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

NCT06593392 ·Status: RECRUITING ·Phase: PHASE2

CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

NCT03998163 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus

NCT02229929 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis

NCT01660243 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

NCT03422653 ·Status: COMPLETED ·Phase: PHASE3

CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

NCT03636269 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Uremic Pruritus With PA101B

NCT02696499 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects

NCT03947970 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia

NCT00358046 ·Status: UNKNOWN ·Phase: PHASE2

Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid

NCT01159054 ·Status: TERMINATED ·Phase: NA

A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

NCT03617536 ·Status: COMPLETED ·Phase: PHASE2

A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus

NCT03218501 ·Status: COMPLETED ·Phase: PHASE2

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

NCT02143648 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis

NCT04470154 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

NCT05885737 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Empagliflozin in Hemodialysis

NCT05786443 ·Status: RECRUITING ·Phase: PHASE2

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associated Pruritus

NCT05135390 ·Status: COMPLETED ·Phase: PHASE3

A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)

NCT00793156 ·Status: UNKNOWN ·Phase: PHASE3

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study

NCT04741386 ·Status: COMPLETED

Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

NCT03864458 ·Status: COMPLETED ·Phase: PHASE2

A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet

NCT04728984 ·Status: UNKNOWN ·Phase: PHASE3

Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus

NCT02671162 ·Status: COMPLETED ·Phase: PHASE2

Alirocumab in Patients on a Stable Dialysis Regimen

NCT03480568 ·Status: UNKNOWN ·Phase: PHASE3

Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)

NCT04123613 ·Status: COMPLETED ·Phase: PHASE2

Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients

NCT00285298 ·Status: COMPLETED ·Phase: PHASE3